Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy. Thiel S, Litvin N, Haben S, Gold R, et al. J Neurol Neurosurg Psychiatry 2024;95:561-570.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thiel S, Litvin N, Haben S, Gold R, et al. Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy. J Neurol Neurosurg Psychiatry 2024;95:561-570.
PMID: 38124108